Evolving Treatment Strategies in HER2-Positive Early Breast Cancer

Opinion
Video

Sandra M. Swain, MD, FACP, FASCO, reviews clinical trial data and how they inform the evolving treatment landscape in HER2+ early breast cancer.

Newsletter

Stay up to date on practice-changing data in community practice.

Recent Videos
2 experts in this video
2 experts in this video
2 experts in this video
2 experts in this video
Related Content